Asymmetric Deactivation of HIV-1 gp41 following Fusion Inhibitor Binding

Open Access

Peer-reviewed

Research Article

Kristen M. Kahle,

Affiliation Department of Biochemistry and Molecular Biology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America
⨯
H. Kirby Steger,

Current address: Department of Protein Therapeutics Development, Bristol-Myers-Squibb, Pennington, New Jersey, United States of America

Affiliation Department of Biochemistry and Molecular Biology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America
⨯
Michael J. Root

* E-mail: michael.root@jefferson.edu

Affiliation Department of Biochemistry and Molecular Biology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America
⨯

Reader Comments (0)

HIV-1
Is the Subject Area "HIV-1" applicable to this article?

Thanks for your feedback.
Membrane fusion
Is the Subject Area "Membrane fusion" applicable to this article?

Thanks for your feedback.
Chemokines
Is the Subject Area "Chemokines" applicable to this article?

Thanks for your feedback.
Viral diseases
Is the Subject Area "Viral diseases" applicable to this article?

Thanks for your feedback.
Cell fusion
Is the Subject Area "Cell fusion" applicable to this article?

Thanks for your feedback.
Chemical dissociation
Is the Subject Area "Chemical dissociation" applicable to this article?

Thanks for your feedback.
Viral entry
Is the Subject Area "Viral entry" applicable to this article?

Thanks for your feedback.
Physical properties
Is the Subject Area "Physical properties" applicable to this article?

Thanks for your feedback.